Listen Now

Topics Covered

  • Overview of Diagnostic Technologies and Biomarkers in the Treatment of Lung Cancer
  • How These Technologies Improve Treatment Decisions and Your Care
  • Why the Molecular Portrait of Lung Cancer is Important
  • The Role of the Pathologist: How Pathology Reports Help Inform Treatment Planning
  • The Benefits of Diagnostic Technologies, Biomarkers, Personalized Care and Predicting Response to Treatment
  • Their Current Application in People Living With Lung Cancer
  • Questions for Our Panel of Experts

Our Panel of Experts

Heather Wakelee, MD

Associate Professor, Department of Medicine, Division of Oncology, Stanford University, Stanford Cancer Institute

Justin F. Gainor, MD

Instructor, Department of Medicine, Harvard Medical School, Assistant in Medicine, Massachusetts General Hospital

Sarah E. Kerr, MD

Senior Associate Consultant, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Assistant Professor, Laboratory Medicine and Pathology, Mayo Clinic

Winfield Boerckel, MSW, MBA

Director of Social Service, Long Island Office, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(63.5 KB)

Workshop Date

This workshop was originally recorded on May 17, 2016.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top